AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Ascioglu, S Rex, JH de Pauw, B Bennett, JE Bille, J Crokaert, F Denning, DW Donnelly, JP Edwards, JE Erjavec, Z Fiere, D Lortholary, O Maertens, J Meis, JF Patterson, TF Ritter, J Selleslag, D Shah, PM Stevens, DA Walsh, TJ
Citation: S. Ascioglu et al., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An internationalconsensus, CLIN INF D, 34(1), 2002, pp. 7-14

Authors: Crokaert, F
Citation: F. Crokaert, Pharmacodynamics, a tool for a better use of antibiotics?, INTEN CAR M, 27(2), 2001, pp. 340-343

Authors: Crokaert, F
Citation: F. Crokaert, Febrile neutropenia in children, INT J ANT A, 16(2), 2000, pp. 173-176

Authors: Viot, M Blanc-Vincent, MP Beal, J Biron, P Boutard, P Malgrange, VB Crokaert, F Escande, MC Fuhrmann, C Lesimple, T Peny, J Pottecher, B Raveneau, J Senet, JM Thyss, A
Citation: M. Viot et al., Infection and cancer: background and current issues, PRESSE MED, 29(29), 2000, pp. 1630-1633

Authors: Malgrange, VB Blanc-Vincent, MP Escande, MC Fuhrmann, C Beal, J Boineau, F Biron, P Crokaert, F Lesimple, T Pottecher, B Raveneau, J Senet, JM Viot, M
Citation: Vb. Malgrange et al., Standards, options and guidelines for good clinical use of blood cultures in oncology, PRESSE MED, 29(27), 2000, pp. 1532-1534

Authors: Pottecher, B Herbrecht, R BlancVincent, MP Malgrange, VB Escande, MC Fuhrmann, C Crokaert, F GoryDelabaere, G Senet, JM Lesimple, T Raveneau, J Beal, J Biron, P Viot, M
Citation: B. Pottecher et al., Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology (vol 87, pg 557, 2000), B CANCER, 87(9), 2000, pp. 630-630

Authors: Pottecher, B Herbrecht, R Blanc-Vincent, MP Malgrange, VB Escande, MC Fuhrmann, C Crokaert, F Gory-Delabaere, G Senet, JM Lesimple, T Raveneau, J Beal, J Biron, P Viot, M
Citation: B. Pottecher et al., Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology, B CANCER, 87(7-8), 2000, pp. 557-591

Authors: Colardijn, F Damas, P De Mol, P Glupczynski, Y Gordus, B Ronveaux, O Struelens, M Thys, JP Verhaegen, J Vogelaers, D Wilmotte, L Bossens, M Byl, B Carpentier, M Claeys, G Crokaert, F Daux, J Dediste, A De Jongh, D Delporte, JP Desmet, F d'Hollander, A Ezzedine, H Fameree, D Garrino, M Goossens, H Govaerts, D Hecq, JD Ieven, G Jacobs, F Jordens, P Larbuisson, W Laterre, PF Lauwers, S Lefebure, B Lievin, V Meert, P Melin, P Mertens, A Moulin, D Peetermans, W Peleman, R Potvliege, C Reynaert, M Rost, F Simon, A Sion, JP Stuyck, J Valcke, Y Van Beek, F Vandercam, B Van Laethem, Y Van Landuyt, H Van Vooren, JP Van Wyngaarden, E Verbist, L Verschraegen, G Vincent, JL Wauters, G Willems, L
Citation: F. Colardijn et al., GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistantbacteria in hospitals, ACT CLIN B, 54(1), 1999, pp. 15-16

Authors: Aoun, M Crokaert, F Paesmans, M Autier, P Klastersky, J
Citation: M. Aoun et al., Imipenem versus targeted therapy in cancer patients, INT J ANT A, 10(4), 1998, pp. 263-270
Risultati: 1-9 |